Eric Beyssac

Prof. Dr. Eric Beyssac

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 October 2017 in Polymers
Verified
Journal Article
Open access
PDF file
BSBruno Solís-Cruz
Bruno Solís-Cruz
DHDaniel Hernandez-Patlan
Daniel Hernandez-Patlan
EBEric Beyssac
Eric Beyssac
JLJuan Latorre
Juan Latorre
Xochitl Hernandez-VelascoXochitl Hernandez-Velasco
Xochitl Hernandez-Velasco
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
Mycotoxins are secondary toxic metabolites that are produced by fungi representing threats to human and animal health. The objective of this study was to evaluate the adsorption capacity of Chitosan (CHI), and three cellulosic polymers (HPMC, CMC, and MCC), on six mycotoxins (AFB1; FUB1; OTA; T-2; DON; and, ZEA) using an in vitro digestive model for poultry. The adsorbent capacity of the materials in the supernatant of each compartment was evaluated by a non-competitive chemiluminescent assay. Control groups with no adsorbent material had an adsorption value of 0.00% against all six mycotoxins that were evaluated. All four materials tested showed significant (p < 0.05) binding activity against all of the mycotoxins when compared with the control non-treated group. However HPMC, CMC, and MCC showed better adsorbent capacity when compared with CHI.

24 October 2012 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
EDEmmanuelle Déat-Lainé
Emmanuelle Déat-Lainé
VHValérie Hoffart
Valérie Hoffart
GGGhislain Garrait
Ghislain Garrait
JJJean-François Jarrige
Jean-François Jarrige
JCJean-Michel Cardot
Jean-Michel Cardot
EBEric Beyssac
Eric Beyssac

1 December 2015 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
HHHassana Hsein
Hassana Hsein
GGGhislain Garrait
Ghislain Garrait
EBEric Beyssac
Eric Beyssac
VHValérie Hoffart
Valérie Hoffart

1 October 2001 in Trends in Biotechnology
Verified
Journal Article
Closed access
SBStéphanie Blanquet
Stéphanie Blanquet
SMSylvie Marol-Bonnin
Sylvie Marol-Bonnin
EBEric Beyssac
Eric Beyssac
DPDenis Pompon
Denis Pompon
MRMichel Renaud
Michel Renaud
MAMonique Alric
Monique Alric

1 November 2010 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ESEmmanuel Scheubel
Emmanuel Scheubel
MLMarc Lindenberg
Marc Lindenberg
EBEric Beyssac
Eric Beyssac
JCJean-Michel Cardot
Jean-Michel Cardot
Standard compendia dissolution apparatus are the first choice for development of new dissolution methods. Nevertheless, limitations coming from the amount of material available, analytical sensitivity, lack of discrimination or biorelevance may warrant the use of non compendial methods. In this regard, the use of small volume dissolution methods offers strong advantages. The present study aims primarily to evaluate the dissolution performance of various drug products having different release mechanisms, using commercially available small volume USP2 dissolution equipment. The present series of tests indicate that the small volume dissolution is a useful tool for the characterization of immediate release drug product. Depending on the release mechanism, different speed factors are proposed to mimic common one liter vessel performance. In addition, by increasing the discriminating power of the dissolution method, it potentially improves know how about formulations and on typical events which are evaluated during pharmaceutical development such as ageing or scale–up. In this regard, small volume dissolution is a method of choice in case of screening for critical quality attributes of rapidly dissolving tablets, where it is often difficult to detect differences using standard working conditions.